Hjem › Kræft (alle typer) › Californien
Kræft (alle typer) kliniske forsøg i Californien
175 studier for Kræft (alle typer) søger deltagere på steder i Californien.
Byer i Californien
- Los Angeles73 studier
- Mountain View40 studier
- San Francisco35 studier
- Baldwin Park33 studier
- San Diego32 studier
- Santa Monica21 studier
- Irvine16 studier
- Orange13 studier
- Santa Rosa11 studier
- Sacramento11 studier
- Santa Barbara7 studier
- Concord7 studier
- Huntington Beach6 studier
- Newport Beach6 studier
- San Jose6 studier
- Long Beach6 studier
- Fullerton5 studier
- Glendale5 studier
- Vallejo5 studier
- Oakland5 studier
- Roseville4 studier
- Richmond4 studier
- Fresno4 studier
- Sunnyvale3 studier
- Modesto3 studier
- Mission Viejo3 studier
- Bakersfield3 studier
- Pleasanton3 studier
- Santa Clara3 studier
Officiel studietekst (engelsk)
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
- GSK Investigational Site, La Jolla
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06796907Distance-Based Exercise to Preserve Function and Prevent Disability
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- og 10 flere
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07059884Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- City of Hope Duarte, Duarte
- University of California at Los Angeles, Santa Monica
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07529808A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- Start Los Angeles /ID# 281533, Los Angeles
RekruttererFase 2
Alder 18 og opefter · Kvinder · Opdateret 1. okt. 2026 · NCT07024784A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- City of Hope National Medical Center /ID# 277005, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277928, Irvine
- UC San Diego Health - Moores Cancer Center /ID# 278836, La Jolla
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07155187A Study of ASP3082 in Adults With Advanced Solid Tumors
- City of Hope National Medical Center, Duarte
- UCLA Santa Monica Hematology Oncology, Santa Monica
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT05382559A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- City of Hope, Duarte
- University of California, Irvine Medical Center - Hematology/Oncology, Orange
- Stanford University School of Medicine, Stanford
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07192471Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Samsun Clinic - Ridley-Tree Cancer Center, Santa Barbara
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07566156A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
- City of Hope National Medical Center /ID# 280273, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067, Irvine
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07409246A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- City Of Hope Comprehensive Cancer Center /ID# 281939, Duarte
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07744126uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- Providence St. Johns Health Center, Santa Monica
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT05874921Registry Study for Radiation Therapy Outcomes
- California Protons Cancer Therapy Center, San Diego
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 29. sep. 2026 · NCT01255748A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Los Angeles
- PHN-012-001 Site, San Diego
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07127874A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
- City of Hope Comprehensive Cancer Center, Duarte
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06884618A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Sansum Clinic, Santa Barbara
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 25. sep. 2026 · NCT05920356Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- University of California San Diego, La Jolla
- Stanford University, Palo Alto
- UCLA Medical Center, Santa Monica
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT04981119A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- UC San Diego Medical Center - Encinitas, Encinitas
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UCI Health - Irvine, Irvine
- og 14 flere
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06989437A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Children's Hospital Los Angeles ( Site 4006), Los Angeles
RekruttererFase 1/2
1 Month – 17 Years · Alle køn · Opdateret 25. sep. 2026 · NCT07630974A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- City of Hope, Duarte
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06150157A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- CBCC Global Research - Comprehensive Blood & Cancer Center, Bakersfield
- TOI Clinical Research, Cerritos
- University of California, San Diego Moores Cancer Center, La Jolla
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06901531Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 1, Duarte
- Quetzal Site 7, Los Angeles
- Quetzal Site 5, Stanford
RekruttererFase 3
Alder 18 til 71 · Alle køn · Opdateret 23. sep. 2026 · NCT07504458Intratumoral N17350 in Advanced Solid Tumors
- The Angeles Clinic and Research Institute, Los Angeles
- UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
- Scripps Clinic Torrey Pines - La Jolla, San Diego
- og 1 flere
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07339176A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- City of Hope National Medical Center /ID# 281322, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 281396, Irvine
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07365241A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- City of Hope /ID# 243157, Duarte
- City Of Hope - Seacliff /ID# 263143, Huntington Beach
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 263144, Irvine
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT04928846Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- UC IRVINE Health, Orange
- UC Davis Comprehensive Cancer Center, Sacramento
- Stanford Cancer Institute, Stanford
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06128551TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Sutter Auburn, Auburn
- Sutter Alta Bates, Berkeley
- The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles
- og 19 flere
RekruttererFase 2
Alder 12 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT02693535Prospective Study to Assess a Diagnostic Aid for Cancer
- Southern California Research Center, Coronado
- Palomar Health, Poway
- South Coast Gynecologic Oncology, San Diego
RekruttererObservationsstudie
Alder 45 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT07046260Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- City Of Hope, Duarte
- University Of California San Diego Moores Cancer Center, La Jolla
- University of California, San Francisco- California, San Francisco
- og 2 flere
RekruttererFase 2/3
Alle aldre · Alle køn · Opdateret 18. sep. 2026 · NCT03435796A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Childrens Hospital Los Angeles ( Site 3006), Los Angeles
RekruttererFase 1/2
1 Month – 17 Years · Alle køn · Opdateret 17. sep. 2026 · NCT06941272Statins to Prevent Cancer Associated Blood Clots
- City of Hope, Irvine
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07303816RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Kadima Neuropsychiatry Institute, San Diego
- Providence Medical Foundation, Santa Rosa
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 15. sep. 2026 · NCT07002034Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
- University of California, San Francisco, San Francisco
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT06633224(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- City of Hope Comprehensive Cancer Center, Duarte
- UCLA Medical Center, Los Angeles
- Stanford Cancer Institute, Stanford
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT04996875A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- University of Southern California /ID# 272414, Los Angeles
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT06953960Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
- UC Davis Health, Sacramento
- UC Davis Medical Center, Sacramento
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT06722508A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Santa Monica
- Research Site, Santa Rosa
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT05123482A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- University of Southern California Norris Comprehensive, Los Angeles
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT06634589Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- UCI Health Chao Family Comprehensive Cancer Center, Orange
- Investigational Site Number: 403, Palo Alto
RekruttererFase 1
Alder 18 og opefter · Mænd · Opdateret 10. sep. 2026 · NCT05997615A Phase 1/1b Study of IAM1363 in HER2 Cancers
- UCSD Moores Cancer Center, La Jolla
- USC Norris Comprehensive Cancer Center, Los Angeles
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06253871Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
- Glendale Adventist Medical Center d/b/a Adventist Health Glendale, Glendale
Rekrutterer
Alder 70 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07629206Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.